Viewing StudyNCT06643000



Ignite Creation Date: 2024-10-26 @ 3:42 PM
Last Modification Date: 2024-10-26 @ 3:42 PM
Study NCT ID: NCT06643000
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-14

Brief Title: Evaluating High-dose Furmonertinib With Bevacizumab and Pemetrexed for EGFRm NSCLC With Leptomeningeal Metastasis
Sponsor: None
Organization: None

Organization Data

Organization: None
Class: None
Study ID: None
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: None
Lead Sponsor Class: None
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators